Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s stock price shot up 0.1% during trading on Thursday . The stock traded as high as $39.25 and last traded at $39.25. 407 shares traded hands during mid-day trading, a decline of 74% from the average session volume of 1,583 shares. The stock had previously closed at $39.20.
Hikma Pharmaceuticals Stock Down 0.2%
The company’s fifty day simple moving average is $36.88 and its 200 day simple moving average is $39.43.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
